A Prospective Randomized Trial Comparing 2 Different Paclitaxel-Coated Balloons in De Novo Coronary Artery Disease
The Genoss PCB, formulated with shellac and vitamin E as excipients, demonstrated angiographic outcomes comparable to a clinically proven PCB in the treatment of de novo CAD. (Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Coronary De Novo Lesions; NCT05096442).
Authors
- Ae‐Young Her (ORCID: https://orcid.org/0000-0002-9990-6843)
- Gyu Chul Oh (ORCID: https://orcid.org/0000-0003-3056-8791)
- Yongwhi Park
- Deok‐Kyu Cho (ORCID: https://orcid.org/0000-0002-3881-411X)
- Sunwon Kim (ORCID: https://orcid.org/0000-0001-7735-1763)
- Bitna Kim (ORCID: https://orcid.org/0000-0003-1835-3974)
- Seung‐Woon Rha (ORCID: https://orcid.org/0000-0001-9456-9852)
- Eun‐Seok Shin (ORCID: https://orcid.org/0000-0002-9169-6968)
- Jang‐Whan Bae (ORCID: https://orcid.org/0000-0003-1362-9804)
- Jong‐Young Lee (ORCID: https://orcid.org/0000-0002-0092-9958)
- Min‐Ku Chon
Institutions
- Ulsan College (KR)
- Kangwon National University (KR)
- Gyeongsang National University (KR)
- Korea University (KR)
- Severance Hospital (KR)
- Korea University Medical Center (KR)
- Ansan University (KR)
- University of Ulsan (KR)
- Kangbuk Samsung Hospital (KR)
- Ulsan University Hospital (KR)
- Pusan National University Yangsan Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Chungbuk National University Hospital (KR)
- Sungkyunkwan University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- JACC Asia
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.jacasi.2024.10.028
- Citations
- 1
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 2.01